Implementing EPR dosimetry for life-threatening incidents: Factors beyond technical performance

Radiation Measurements

Volumn 42, Issue 6-7, 2007, Pages 1099-1109

  Flood, Ann Barry ^a   Bhattacharyya, Shayan ^a,b   Javier Nicolalde, R ^a,b   Swartz, Harold M ^a,b  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

EPR dosimetry; Policy making; Radiation exposures; Regulatory processes; Triage

Indexed keywords

IONIZING RADIATION; PARAMAGNETIC RESONANCE; RADIATION DETECTORS; RADIATION EFFECTS;

POLICY MAKERS; RADIATION EXPOSURES; REGULATORY CLEARANCE; REGULATORY PROCESSES; TRIAGE;

DOSIMETRY;

EID: 34548823477     PISSN: 13504487     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radmeas.2007.05.042     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention (CDC), 2005. Acute radiation syndrome: a fact sheet for physicians. Retrieved December 25, 2006 from 〈http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp〉.
2. Department of Homeland Security (DHS), 2002. National Response Plan. Initial Draft. Retrieved December 28, 2006 from 〈http://www.nemaweb.org/docs/national_response_plan.pdf〉.
3. Department of Homeland Security (DHS), 2004. National Response Plan. Retrieved December 28, 2006 from 〈http://www.dhs.gov/xprepresp/committees/editorial_0566.shtm〉.
4. Department of Homeland Security (DHS), 2006a. Remarks by Secretary of Homeland Security Michael Chertoff at the Brookings Institution, Washington, DC, June 1, 2006. Retrieved January 27, 2007 from 〈http://www.dhs.gov/xnews/speeches/speech_0283.shtm〉.
5. Department of Homeland Security (DHS), 2006b. Preparedness and Response. Retrieved December 25, 2006 from 〈http://www.dhs.gov/xprepresp/〉.
6. Diamond, F., 2003. How to manage the worried well. Managed Care (online). Retrieved December 25, 2006 from 〈http://www.managedcaremag.com/archives/0306/0306.worriedwell.html 〉.
7. Federal Register, 2006. Rules and regulations. Medical devices. Exception from General Requirements for Informed Consent, 71(109), pp. 32827-32834.
8. Flood, A.B., Zinn, J., Scott, W.R., 2005. Organizational performance: managing for efficiency and effectiveness. In: Shortell, S.M., Kaluzny, A. (Eds.), Health Care Management: Organizational Design and Behavior, fifth ed., Delmar Publisher, Albany, NY.
9. Food and Drug Administration (FDA), 2002. New drug and biological drug products: evidence to demonstrate effectiveness of new drug when human efficacy studies are not ethical or feasible. Retrieved December 28, 2006 from 〈http://www.fda.gov/OHRMS/DOCKETS/98fr/98n-0237-nfr0001-vol1.pdf〉
10. Food and Drug Administration (FDA), 2003a. Overview: FDA regulation of medical devices. Retrieved December 26, 2006 from 〈http://www.qrasupport.com/FDA_MED_DEVICE.html〉.
11. Food and Drug Administration (FDA), 2003b. What is third party review? Retrieved December 28, 2006 from 〈http://www.fda.gov/cdrh/thirdparty/thirdparty-about.html#1〉.
12. Food and Drug Administration (FDA), 2005. Draft guidance emergency use authorization of medical products. Retrieved December 28, 2006 from 〈http://www.fda.gov/oc/bioterrorism/emergency_use.html〉.
13. Food and Drug Administration (FDA), 2006. Title 21-Food and drugs Chapter I-Food and Drug Administration, Department of Health and Human Services; Subchapter H-Medical Devices; Part 814-Premarket approval of medical devices, Subpart H-Humanitarian use devices. Retrieved December 28, 2006, from; 〈http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch. cfm?fr=814.100〉.
14. Health and Human Services (HHS), 2004. HHS fact sheet-Project Biosheld. Accessed January 27, 2007 from 〈http://www.hhs.gov/news/press/2004pres/20040721b.html〉.
15. Homeland Security Institute, 2006. Homeland Security Act of 2002: Section 312. Retrieved December 25, 2006 from 〈http://www.homelandsecurity.org/LegislativeFoundation2.asp〉.
16. Longest, Jr., B.B., 2006. Health Policymaking in the United States, fourth ed. Health Administration Press, Chicago, 439pp.
17. Meade, C., Molander, R.C., 2006. Considering the effects of a catastrophic terrorist attack. Technical Report of the RAND Center for Terrorism Risk Management Policy. RAND Corporation, Santa Monica, CA, p. 72.
18. Salikhov I.K., and Swartz H.M. Measurement of specific absorption for clinical EPR at 1200 MHz. Appl. Magn. Reson. 29 (2005) 287-291
19. Stein B.D., Tanielian T.L., Eisenman D.P., Keyser D., Burnam M.A., and Pincus H.A. Emotional and behavioral consequences of bioterrorism: planning a public health response. Milbank Quart. 82 3 (2004) 413-455
20. Swartz H.M., Khan N., Buckey J., Comi R., Gould L., Grinberg O., Hartford A., Hopf H., Hou H., Hug E., Iwasaki A., Lesniewski P., Salikhov I., and Walczak T. Clinical applications of EPR: overview and perspectives. NMR Biomed. 17 (2004) 335-351
21. Waselenko J.K., MacVittie T.J., Blakely W.F., Pesik N., Wiley A.L., Dickerson W.E., Tsu H., Confer D.L., Coleman C.N., Seed T., Lowry P., Armitage J.O., and Dainiak N. Medical management of the acute radiation syndrome: recommendations of the strategic national stockpile radiation working group. Ann. Intern. Med. 140 12 (2004) 1037-1051